Ozempic and Wegovy both contain the active ingredient semaglutide, a GLP-1 receptor agonist that helps with weight loss via three pathways: 1) lowering the body set weight, essentially a thermostat determining when you feel full, that is believed to be located in the hypothalamus 2) delayed gastric emptying leading to a feeling of fullness 3) stimulation of insulin release from the pancreas that also leads to a feeling of satiety The only other difference between these two medications is that while Ozempic goes up to a maximum dose of 2mg, Wegovy has a maximum dose of 2.4mg
Barrett TS et al
Processing GLP-1 prescriptions for obesity often involves more complex interactions with insurers, including verification of coverage, handling of denials, and communication with prescribers
If they dampen the pleasure of eating, could they also dampen the pleasure of romance, sex, music, travel, or simply being alive
Selling pills that dont do anything sounds like a terrible business modelwho would even try something like that